Product Safety Recalls

Product Recall Tracker

MEDROXYPROGESTERONE ACETATE Recall D-1146-2022

Description: medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Manufactured for: Northstart Rx LLC, Memphis, TN, 38141, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India , NDC 16714-981-01.

MEDROXYPROGESTERONE ACETATE Recall D-1146-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1146-2022
Event ID90151
BrandMEDROXYPROGESTERONE ACETATE
Generic NameMEDROXYPROGESTERONE ACETATE
ManufacturerMEDROXYPROGESTERONE ACETATE
Original Package?1
Active SubstanceMEDROXYPROGESTERONE ACETATE
Drug RouteINTRAMUSCULAR
DistributionUSA Nationwide
Quantity180813 syringes
Recall ReasonLack of assurance of sterility
Drug ClassificationClass II
Drug Code Info20220622
Product NDC16714-981
Recall Initiation Date20220506
Report Date20220622
Classification Date20220610
Address2 Independence Way
Princeton, NJ 08540-6620
United States
Recalling FirmSUN PHARMACEUTICAL INDUSTRIES INC
Unique Ingredient IdentifierC2QI4IOI2G
Drug Application NumberANDA210760
Structured Product Labeling (SPL ID)72bfa421-1b70-4cc4-a366-771028b02cff
Structured Product Labeling (SPL Set ID)7cc31691-8268-4e59-b645-19246931f03c
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.